Proven Industry Leader StudyKIK is recognized as a global leader in patient recruitment and retention technology, with a strong track record of connecting over 3.1 million patients to clinical studies and earning industry awards for engagement innovation. This reputation positions the company as a trusted partner for healthcare organizations seeking reliable clinical trial solutions.

Recent Acquisition Advantage Since being acquired by Syneos Health in September 2021, StudyKIK has benefited from the backing of a major industry player, expanding its resources and technical capabilities. This integration offers additional avenues for collaboration and upselling advanced recruitment and retention services to a broader client base.

Comprehensive Technology Stack With a focus on innovative digital solutions like telemedicine, eConsent, and retention apps, StudyKIK provides a platform that enhances patient engagement across various stages of clinical trials. Leveraging this technology can open opportunities to offer integrated tech solutions to sponsors and CROs looking to modernize their trial processes.

Market Expansion Potential Operating with a moderate revenue range of $25 million to $50 million and a sizable workforce, StudyKIK is well-positioned for growth in the increasingly competitive clinical research landscape, especially among companies aiming to improve recruitment efficiency and patient diversity, presenting strategic upsell opportunities.

Focus on Engagement Innovation Award-winning initiatives like the Oncology Study App demonstrate StudyKIK’s commitment to improving participant communication and retention, representing a strong value proposition for potential clients seeking proven solutions to reduce trial dropout rates and improve compliance.